MedTrace Logo

A Systems Approach to Immunotherapy Biomarker Identification Within the Postoperative Wound-Healing Microenvironment in Patients With Gastroesophageal Cancer

NCT05338060 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2026-02-11

No results posted yet for this study

Summary

The purpose of this research is to collect surgical drain fluid and blood from patients who have undergone surgery for gastric or esophageal cancer, and to analyze the fluid and blood using a variety of laboratory techniques for molecular markers capable of predicting response to immunotherapy.

Conditions

Interventions

OTHER

prospective collection of surgical exudates (SEs)

prospective collection of surgical exudates (SEs) from patients who are hospitalized for post-operative recovery from esophagectomy or gastrectomy for gastroesophageal cancer

Sponsors & Collaborators

  • George Mason University

    collaborator OTHER

  • Inova Health Care Services

    lead OTHER

Principal Investigators

  • Raymond Wadlow, MD · Inova Schar Cancer Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-26
Primary Completion
2025-08-05
Completion
2025-08-05

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05338060 on ClinicalTrials.gov